Diabetes: Injectors insulin

INJECTING

Injectors

What is the ‘jet’ injector?

This is a needle-free injector, which works by penetrating the skin with insulin using very high pressure jets. It is not entirely painless and is fairly bulky. The recent model available in the UK (MHI-500) has been superceded by a new model, SQ-PEN.

Injectors insulin

Practical aspects of pens, needles, syringes and bottles

When I was discharged from hospital with newly-diagnosed diabetes I was given a pen device and a few disposable syringes and needles for my injections. How do I obtain more?

Pen devices, disposable insulin syringes and pen needles are available free on prescription. Your CP will supply you with a prescription for any make of insulin syringe and/or insulin pen needles that you choose, and they can then be obtained without charge from a chemist.

Alternatively you can buy them at your own cost directly from the chemist without a prescription, or you can send for them by post from suppliers such as Owen Mumford (Medical Shop).

What is the best way of disposing of insulin syringes and pen needles?

There is a device available called the BD Safe-Clip® which cuts the needle off the top of a syringe or insulin pen and retains it in the device. Once the needle is clipped off, put the used syringe or pen needle hub into a rigid sealable container (available on prescription as a Sharps bin) along with your lancets and follow your local council guidelines for safe disposal of medical waste. Some local authorities provide special containers and a collection service for people who are treated with insulin; however, there is no national policy.

The BD Safe-Clip is available free on prescription from your CP.

I have heard that pen needles and disposable syringes can be reused. How many times can they be reused and how can they be kept clean in between injections?

While pen needles and disposable syringes are designed to be used only once, some people do reuse them. However, reusing needles causes them to become blunt, and they can bend very easily. The tiny point on the end can also break off and remain embedded in the flesh. Needles have a fine coating of lubricant on them so they glide in and out of the skin, and reusing them removes this lubricant and may cause a more painful injection. So there are many reasons to use each needle once only.

If you decide to reuse them make sure the protective cover is placed over the needle.

There is a bewildering array of syringes and needles on the market. Which are the best types to use?

In the UK we use three sizes of syringe. They are used with U100 insulin, which is the standard strength of insulin in the UK and most countries, containing 100 units of insulin per 1 millilitre.

• The 0.5 mL syringe. This is marked with 50 single divisions for taking not more than 50 units of insulin in one injection.
• The 1 mL syringe, marked up to 100 units in 2 unit divisions for those taking more than 50 units of insulin in one injection.
• The 0.3 mL syringe, designed for children or those taking less than 30 units of insulin in one injection.

The most popular make is the BD syringe which comes complete with a fixed Micro-Fine+ 12.7 mm needle, but there are several other makes available.

All these syringes are marked with the word INSULIN on the side of the syringe and graduated in units of insulin. No other type should be used to inject insulin.

10% Discount on www.canadianhealthcaremalll.com

10% Discount on Canadianhealthcaremalll.com

We are pleased to inform you that in our shop all month 10% discount on all products! In order to take advantage of a discount - just enter the coupon number when paying for your purchase. Waiting For You. And Happy New Year. Protect your health. CanadianHealthCareMall

Eosinophils play a key role in airway remodeling

In children with asthma who were not receiving any controller medications, sputum amphiregulin level was negatively correlated with the provocative concentration of methacholine causing a 20% fall in F'EV_X (r = —0.398; p = 0.008). Conclusions: Our findings suggest that childhood asthma is associated with sputum amphiregulin, whereas EB is not, and that sputum amphiregulin would be a supportive marker of airway inflammation in asthma.

Abbreviations: AHR = airway hyperresponsiveness; BD = bronchodilator; EB = eosinophilic bronchitis; ECP = eosinophil cationic protein; FEF_25-75% = forced expiratory flow, midexpiratory phase; ICS = inhaled corticosteroid; IQR = interquartile range; PC₂₀ = provocative concentration of methacholine causing a 20% fall in FEV₁

Airway remodeling and eosinophilic airway inflammation, which are characteristic features of asthma in adults, are already present in children with asthma and even in pre-school-aged children who wheeze. There is evidence that eosinophils play a key role in airway remodeling, which produces a wide range of proteins in fibrogenesis and angiogenesis, particularly transforming growth factor-P and other cytokines. Eosinophils also are increased within the airways in patients with nonasthmatic eosinophilic bronchitis (EB) to levels similar to those found in patients with asthma. EB has emerged from the study of chronic cough, and is characterized by eosinophilic inflammation, increased exhaled nitric oxide levels, increased basement membrane thickening, and normal spirometry findings, without airway hyperresponsiveness (AHR). Although the pathogenesis of EB is still unclear, especially in children, its immunopathologic features are distinct from those of asthma in that EB shows no evidence of the overexpression of interleukin-4 or interleukin-13 by mast cells or mast cell colonization to airway smooth muscle.

Amphiregulin was originally classified as a member of the epidermal growth factor family, which plays important roles in cell proliferation, survival, and differentiation.

Canadian Health and Care Mall

Treatment: For Children

A mother must not only give birth to a child, but she shall also breastfeed it. That milk shall be incorrupt. So many mothers have poisoned their children with their bad milk. If she is angry several times a day, a few hours after that she will poison her child.

Treatment: For Children

If the mother is healthy, the more your child sucks, the better. Children, who have sucked for two or three years, are healthier. A healthy person is also good.

Every mother should know how to treat her children. Mother must give first aid. The first task of a mother is to give castor oil to an ill child. Then it shall drink several cups of warm water, and then the mother shall cook a vegetarian potato soup for the child. This is the first aid for every patient. You ask why you should drink hot water. It is very simple. While eating, fat deposits remain along the walls of the stomach and intestines that impede proper digestion. Hot water dissolves them and regulates the processes in the stomach and intestines.

If the child is anemic, give it more pears and cucumbers. If its character is a bit rough, feed it with apples. If he lacks noble qualities, feed it with cherries. Give children only fresh food, mainly fruits.

The first task of the future education of children will be the condition of the digestive system to be controlled. A healthy digestive system provides a normal brain system. If those two systems are in good working order, the function of the respiratory system is also good. These are the three main systems that regulate human thoughts and feelings. If they work well, thoughts and feelings of people will be expressed properly.

The child that eats bread, baked in the embers, has a hundred times bigger opportunity to become a distinguished professor than the child that eats cakes, chocolate and sweets.

When your children are ill, it is good the bone behind their ears to be massages - there is a living center. These massages make the organism elastic and durable.

If a child has been ill for a few months, the first thing that shall be done after its recover is to be bathed and dressed in new clothes. The old clothes, in which it has spent the illness, shall be burned. Old clothes are penetrated with negative states and therefore they shall be burned, and you shall not give them to poor. New clothes shall be given to the poor.

Give somebody to eat dry corn for a week and you will see him transformed. For naughty children, the mother shall apply the same regime.

If a child is capricious, obstinate, the mother shall give him two nuts. The number two is magnetic method. If the child is unbalanced in nature, give him three nuts or apples. The number three is a law of balance. Sometimes nuts may affect badly the organism (when taken in large amounts), because they contain lots of iodine. So, nuts are also able to poison someone. If you want to develop the child's sense of justice, give it four nuts. You shall give for feelings, in general - five nuts, religious feelings - seven nuts, critical and philosophical mind - seven nuts. Do not give more than nine nuts to your children.

www.canadianhealthcaremalll.com

TNF-Receptor Subtype Expression

For all correlations tested, inverse relationships between protein release and airway obstruction were found. With the exception of FEV₁/FVC (percentage predicted) vs GRO-a (p = 0.06, r = — 0.49), all correlations reached the level of significance (Table 2). Furthermore, no differences were seen with respect to the unstimulated protein release, and both cytokines responded nonsignificantly to IFN-y stimulation, which reflects the mRNA results as well.

Table 1—Increase in Stimulated Epithelial mRNA Expression Levels of IL-8 and GRO-a Relative to Unstimulated mRNA Levels*
 

	Basal	TNF-a	Fold Increase in TNF-a	IFN-y	Fold Increase in IFN-y
IL-8 mRNA
Smokers	1.0 (0.5-3.2)	4.6 (3.1-9.9)	4.7(1.8-14.1)	0.4 (0.1-1.3)	0.3 (0.1-0.9)
COPD	3.3 (0.2-19.1)	12.9 (5.4-36.9)t	5.7 (1.9-70.0)	1.9 (0.3-12.4)	0.9 (0.1-1.8)
GRO-a
mRNA Smokers	4.3 (0.9-8.9)	7.3 (3.8-11.2)	2.0 (0.7-9.1)	4.3 (0.8-6.5)	1.0 (0.2-2.0)
COPD	4.1 (0.9-12.3)	16.2 (8.1-81.8)t	4.3 (2.5-9.9)	5.7 (2.8-17.3)	1.8 (0.6-3.2)

*Data are presented as median (range). tp < 0.01 vs smokers without airway obstruction.

TNF-Receptor Subtype Expression

In addition to the TNF-a-induced cytokine responses, the expression levels of the TNF-receptor subtypes—p55 TNF-receptor subtype (TNF-R55) and p75 TNF-receptor subtype (TNF-R75)—were quantified at the steady-state mRNA level by means of light cycler measurements. As shown in Figure 3, both TNF receptors were detectable in PBECs. The expression levels of TNF-R55 compared to TNF-R75 were 5,670-fold and 4,730-fold higher in smokers without airflow limitation and patients with COPD, respectively. No significant differences in the expression levels between groups were detected for TNF-R55 (p = 0.8) nor for TNF-R75 (p = 0.6). Table 2 —Correlations Between TNF-a-Induced Protein Release of IL-8 or GRO-a in PBECs and Lung Function 

Parameters*

 

Variables	IL-8		GRO-a
	1 r Value	1 p Value	i r Value	l p Value
IL-8			0.72	< 0.01
FEV1, L	— 0.63	< 0.01	— 0.67	< 0.01
FEV1, % predicted	— 0.52	< 0.05	— 0.67	< 0.01
FEV1/FVC, %	— 0.67	< 0.01	— 0.59	< 0.05
FEV1/FVC, % predicted	— 0.63	< 0.01	— 0.49	NS

*NS = not significant.

Pneumonia

In our study, 44% of the patients had autopsy evidence of generalized atherosclerosis. PTE was another common cause of death and was frequently unrecognized. Only one-third of these patients received IV heparin. Previous studies have reported COPD as an independent risk factor for PTE as well as a high prevalence of PE in patients with unexplained exacerbations of COPD, but clear guidelines for pharmacologic PTE prophylaxis, especially in an outpatient setting, have not been defined. 

Canadian Health Care Mall Pneumonia

Although the prevalence of PE in patients admitted to the emergency department for an acute exacerbation of COPD is found to be as low as 3%, our findings suggest that PTE has to be taken into consideration in hospitalized patients with severe exacerbation of COPD, and appropriate treatment cannot wait until the diagnosis is confirmed. In the absence of contraindications, systemic anticoagulation should be started according to clinical suspicion and continued until PTE is excluded by an appropriate diagnostic study. Pneumonia was the common cause of death in our study, despite the application of antibiotics. 

The presence of multiresistant bacterial strains, progression to severe sepsis, and delayed presentation are some of the possible causes. These patients often live in bad socioeconomic conditions, with a poor quality of life, and do not present to the hospital on time. COPD patients hospitalized with community-acquired pneumonia have been previously reported to have worse clinical outcomes and higher 30- and 90-day mortality than patients without COPD. Therefore, COPD should be included in a pneumonia severity scoring system as one of the predictors of higher mortality risk. 

Our study is limited by the small number of patients because the autopsy was performed only in patients who died in the first 24 h after hospital admission. The data regarding the clinical diagnosis of comorbidities and previous outpatient therapy may be incomplete, and the retrospective design of the study precluded a meaningful analysis of physicians’ intention-to-treat-associated conditions.

Canadian Health Care Mall: Azithromycin

Azithromycin Attenuated Ovalbumin-Dependent Airway Inflammation Is Independent of Ovalbumin-Specific IgE Production We next quantified the serum concentration of ovalbumin-specific IgE to confirm equal allergen sensitization in all cohorts of mice and to exclude the possibility that azithromycin attenuated the allergic inflammation by altering IgE production. 

Naive mice and mice that received only an ovalbumin challenge (without sensitization) produced no ovalbumin-specific IgE. Mice that were sensitized and challenged with ovalbumin had a significant increase in ovalbumin-specific IgE production (699.8 ± 178.2 ng/mL) that was not significantly changed by treatment with PBS solution (885.1 ± 193.8 ng/mL) or azithromycin (829 ± 231.1 ng/mL; p = 0.80). 

Azithromycin Attenuated Ovalbumin-Dependent Airway Inflammation Is Associated With Decreased Concentrations of BAL Fluid Inflammatory Mediators Based on the affect of azithromycin on inflammatory cell influx, we proposed that azithromycin-dependent attenuation of allergic airway inflammation would also be associated with decreased concentration of BAL fluid cytokines and chemokines. 

Compared to ovalbumin sensitized and challenged mice treated with PBS solution, treatment with azithromycin attenuated the expression of multiple BAL fluid cytokines, chemokines, and growth factors as measured by multiplex flow cytometry based assay (Fig 3A-F, column 4 vs 5). Importantly, we observed a statistically significant azithromycin- dependent decrease in interleukin (IL)-13 and IL-5, and a trend toward a decrease in IL-4, proteins known to mediate allergic airway inflammatory phenotypes in the airway (eg, mucous cell metaplasia and eosinophilic inflammation). 

In addition, azithromycin attenuated the expression of multiple other chemokines and inflammatory mediators (CCL2/JE, CCL3/macrophage inhibitory protein [MIP]-1a, CCL4/MIP-1P, CXCL1/KC, IL-1a, IL-10, and granulocyte-macrophage colony-stimulating factor), but had no effect on concentration of IL-6, IL-9.

Heparin-induced thrombocytopenia (HIT)

Heparin-induced thrombocytopenia (HIT) is a prothrombotic drug reaction caused by plateletactivating IgG that recognizes multimolecular platelet factor 4 (PF4)/heparin complexes. The frequency of HIT is higher with unfractionated heparin (UFH) than with low-molecular-weight heparin (LMWH) based on two meta-analyses that analyzed randomized trials 848 and prospective observational studies of postoperative thromboprophylaxis. 

The PROTECT (The Prophylaxis for Thromboembolism in Critical Care Trial) randomized trial, which compared UFH with the LMWH, dalteparin, for thromboprophylaxis in mixed surgical-medical critically ill patients, used the serotonin-release assay (SRA) to classify patients as having HIT among those who underwent serologic investigations because of thrombocytopenia or thrombosis. 

Seventeen patients had HIT based on SRA-positive (SRA+) status: five in the dalteparin group and 12 in the UFH group, a nonsignificant difference in the intention-to-treat analysis (five of 1,873 [0.3%] vs 12 of 1,873 [0.6%]; hazard ratio, 0.47; 95% CI, 0.16-1.35; P = .16; Fisher exact test, P = .14). However, the difference in HIT was statistically significant in a prespecified per-protocol analysis that excluded two patients who had VTE at trial entry: dalteparin, three of 1,566 (0.2%) vs UFH, 12 of 1,561 (0.8%); hazard ratio, 0.27 (95% CI, 0.08-0.98); P = .046; Fisher exact test, P = .021. The current study had two objectives. 

First, we sought to characterize the clinical picture of HIT in critically ill patients enrolled in PROTECT (timing and severity of thrombocytopenia and frequency of HIT-associated thrombosis and other sequelae [eg, HIT-associated anaphylactoid reactions]). We were particularly interested in determining whether SRA+ patients in whom heparin was continued (because of low clinical suspicion of HIT) had subsequent platelet count recovery, a phenomenon reported in some patients with HIT who continue to receive heparin.  

Second, we sought to determine whether the reduced risk of HIT with dalteparin observed in PROTECT reflected decreased seroconversion (ie, lower immu-nogenicity) by the study drug (dalteparin vs UFH), or decreased breakthrough of HIT-related thrombocytopenia and/or thrombosis among SRA+ patients while receiving the study drug (dalteparin vs UFH), or both. We undertook this analysis to address the role of confounding open-label heparin in PROTECT and because there are two distinct heparin-dependent pathophysiologic events to explain a given episode of HIT: (1) formation of HIT antibodies (seroconversion to SRA+ status) and, subsequently, (2) platelet activation, resulting in thrombocytopenia and/or thrombosis among SRA+ patients (breakthrough).

Canadian Health and Care Mall